The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10846 malaria professionals are enjoying the free benefits of MalariaWorld today

coronavirus

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism

February 2, 2021 - 16:25 -- Open Access
Author(s): 
Badraoui R, Adnan M, Bardakci F, Alreshidi MM
Reference: 
Molecules. 2021 Jan 28;26(3):673

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection inducing coronavirus disease 2019 (COVID-19) is still an ongoing challenge. To date, more than 95.4 million have been infected and more than two million deaths have been officially reported by the WHO. Angiotensin-converting enzyme (ACE) plays a key role in the disease pathogenesis.

Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter

January 5, 2021 - 15:18 -- Open Access
Author(s): 
Ippolito MM, Flexner C
Reference: 
Clin Infect Dis. 2020 Dec 31;71(11):2965-2967

Clinical trials of hydroxychloroquine (HCQ) for the treatment of coronavirus infection 2019 (COVID-19) are moving forward on the heels of conflicting, and sometimes controversial, observational studies out of China and France from the first months of the pandemic [1–3].

Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic

April 23, 2020 - 10:23 -- Open Access
Author(s): 
Napoli PE, Nioi M
Reference: 
J Clin Med. 2020 Apr 16;9(4). pii: E1138

In the current work, we discovered and analyzed the epidemiological paradox between coronavirus disease 2019 (COVID-19) and malaria in the initial phase of the ongoing pandemic. From the analysis of distribution data, the endemic presence of malaria seems to protect some populations from COVID-19 outbreak, particularly in the least developed countries.

Subscribe to RSS - coronavirus